Core Insights - The "AI + Inspection, Intelligent New Era: Comprehensive Analysis of Blood Smears" conference recently showcased the Cygnus Automated Hematology Morphology Analysis System, the first AI Class III medical device approved for in vitro diagnostics in China [1][2] - The Cygnus system significantly improves the detection rate of abnormal cells in peripheral blood smears, utilizing a "full membrane scanning mode" to analyze all white blood cells accurately [1] - The system has a verification accuracy of ≥90% and is unaffected by the fatigue or experience differences of laboratory personnel, allowing for precise analysis even with low-quality samples [2] Company and Industry Developments - Xiaoying Technology has actively participated in the "Peripheral Blood Cell Morphology Analysis Technology Application Scenario Project" in Haidian District, Beijing, demonstrating the system's effectiveness in improving testing efficiency and disease detection rates [2] - The Cygnus system is positioned as a key technological support for early diagnosis, treatment, and management of blood diseases, enhancing the quality of regional medical services [2]